Interim results of a phase II multi-center study of oncolytic adenovirus DNX-2401 with pembrolizumab for recurrent glioblastoma; Captive study (Keynote-192) Meeting Abstract
| Authors: | Aiken, R.; Chen, C.; Cloughesy, T.; Colman, H.; Daras, M.; Groves, M.; Khagi, S.; Kumthekar, P.; Lang, F.; Nassiri, F.; Ong, S.; Ramakrishna, R.; Sonabend, A.; Vogelbaum, M.; Zadeh, G.; Agensky, L.; Bidwell, C.; Watkins, B.; Tufaro, F.; Peterkin, J. |
| Abstract Title: | Interim results of a phase II multi-center study of oncolytic adenovirus DNX-2401 with pembrolizumab for recurrent glioblastoma; Captive study (Keynote-192) |
| Meeting Title: | 24th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 21 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2019 Nov 22-24 |
| Meeting Location: | Phoenix, AZ |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-11-01 |
| Start Page: | vi8 |
| End Page: | vi9 |
| Language: | English |
| ACCESSION: | WOS:000509478700033 |
| PROVIDER: | wos |
| PMCID: | PMC6847955 |
| DOI: | 10.1093/neuonc/noz175.032 |
| Notes: | Meeting Abstract: ATIM-33 -- Source: Wos |
